PTX3 exerts antiangiogenic and anticarcinogenic effects (Figure 3), primarily by inhibiting the FGF/FGFR pathway (137), as well as exerting tumor-suppressing or -promoting effects through other signaling pathways, including NF-κB and PI3K/AKT (Table 1) (69). Here, NFKB1 is linked to neoplasm.